In GBM cells, upregulation of nuclear factor erythroid 2-related factor 2 (Nrf2) promotes the expression of glucose-6-phosphate dehydrogenase (G6PD) and transketolase (TKT) to inhibit ROS-induced apoptosis [4]. The gene discussed is TKT; the disease is glioblastoma.